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A combinatorial regulatory signature
controls terminal differentiation
of the dopaminergic nervous system
in C. elegans
Maria Doitsidou,1,2,3,4,8,9 Nuria Flames,1,2,5,8,9 Irini Topalidou,6,7 Namiko Abe,1 Terry Felton,1,2
Laura Remesal,1,2,5 Tatiana Popovitchenko,1,2,3,4 Richard Mann,1 Martin Chalfie,6 and Oliver Hobert1,2
1Department of Biochemistry and Molecular Biophysics, 2Howard Hughes Medical Institute, Columbia University Medical
Center, New York, New York 10032, USA; 3Norwegian Center for Movement Disorders, Stavanger University Hospital,
Stavanger N-4068, Norway; 4Center for Organelle Research, University of Stavanger, Stavanger N-4036, Norway; 5Instituto de
Biomedicina de Valencia-Consejo Superior de Investigaciones Cientı´ficas (IBV-CSIC), 46010 Valencia, Spain; 6Department of
Biological Sciences, Columbia University, New York, New York 10027, USA; 7Department of Biochemistry, University of
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Terminal differentiation programs in the nervous system are encoded by cis-regulatory elements that control the
expression of terminal features of individual neuron types. We decoded the regulatory information that controls
the expression of five enzymes and transporters that define the terminal identity of all eight dopaminergic neurons
in the nervous system of the Caenorhabditis elegans hermaphrodite. We show that the tightly coordinated, robust
expression of these dopaminergic enzymes and transporters (‘‘dopamine pathway’’) is ensured through a combi-
natorial cis-regulatory signature that is shared by all dopamine pathway genes. This signature is composed of an
Ets domain-binding site, recognized by the previously described AST-1 Ets domain factor, and two distinct types of
homeodomain-binding sites that act in a partially redundant manner. Through genetic screens, we identified the
sole C. elegans Distalless/Dlx ortholog, ceh-43, as a factor that acts through one of the homeodomain sites to
control both induction and maintenance of terminal dopaminergic fate. The second type of homeodomain site is
a Pbx-type site, which is recognized in a partially redundant and neuron subtype-specific manner by two Pbx
factors, ceh-20 and ceh-40, revealing novel roles of Pbx factors in the context of terminal neuron differentiation.
Taken together, we revealed a specific regulatory signature and cognate, terminal selector-type transcription
factors that define the entire dopaminergic nervous system of an animal. Dopaminergic neurons in the mouse
olfactory bulb express a similar combinatorial transcription factor collective of Ets/Dlx/Pbx factors, suggesting
deep phylogenetic conservation of dopaminergic regulatory programs.
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The underlying basis of the functional and anatomical
diversity of cell types in the nervous system is the differ-
ential expression of neuron-type-specific gene batteries,
which are composed of terminal differentiation genes
whose products define the specific properties of a mature
neuron throughout its lifetime (Hobert et al. 2010). These
‘‘terminal differentiation’’ or ‘‘effector’’ genes include, for
example, neurotransmitter-synthesizing enzymes, neu-
rotransmitter receptors, transporters, the many ion chan-
nels that tune the electric properties of a neuron, specific
synaptic adhesion molecules, and many others. With this
notion in mind, one approach to understand the genera-
tion of neuronal diversity is a ‘‘bottom-up’’ approach that
focuses on studying the cis-regulatory principles by which
the expression of terminal gene batteries is controlled. In
spite of the conceptual promise of such an approach, the
cis-regulatory architecture of neuronal gene batteries is
generally poorly described.
The neurotransmitter dopamine controls a number of
diverse behaviors across the animal kingdom (Iversen and
Iversen 2007). Dopaminergic neurons are molecularly
defined through the coordinated expression of five genes
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(‘‘dopamine pathway genes’’) that encode proteins involved
in the synthesis of dopamine (tyrosine hydroxylase [TH],
GTP-cyclohydrolase [GTPCH], and aromatic amino acid
decarboxylase [AAAD]), packaging of dopamine into
synaptic vesicles (vesicular monoaminergic transporter
[VMAT]), and reuptake of dopamine after synaptic release
(dopamine transporter [DAT]) (Fig. 1A; Flames and Hobert
2011). Surprisingly little is known about the cis-regulatory
elements and trans-acting factors that ensure coordinated
expression of these specific genes. Understanding in detail
how expression of these genes is regulated will provide
insights into general regulatory principles of nervous
system development, and such insights may also instruct
our ability to generate this neuron type through repro-
gramming approaches in vitro or in vivo.
Dopaminergic neurons as well as dopamine pathway
genes are phylogenetically conserved. The nematode
Caenorhabditis elegans contains eight dopaminergic neu-
rons in the hermaphroditic nervous system that fall into
four distinct classes: the embryonically generated ADE,
CEPD, and CEPV classes in the head and the post-
embryonically generated PDE class in the midbody
(Fig. 1A; Sulston et al. 1975; Flames and Hobert 2011).
Using the amenability ofC. elegans to transgenic reporter
gene studies, we previously dissected the cis-regulatory
control regions of the five dopamine pathway genes
(cat-2/TH, cat-4/GTPCH, bas-1/AAAD, cat-1/VMAT,
and dat-1/DAT) and identified a shared cis-regulatory
motif—termed the dopaminergic (DA) motif—that is
present in all five dopamine pathway genes (Flames and
Hobert 2009). Through mutational analysis, we found
that the DA motif is required for all five genes to be
expressed in all eight dopaminergic neurons (Fig. 1B). We
showed that this cis-regulatory motif is recognized by the
Ets domain factor AST-1, a terminal selector-type tran-
scription factor (Flames and Hobert 2009). Terminal
selectors are transcription factors that define the terminal
identity state of individual neuron types through direct
regulation of many identity features of a specific neuron
type (Hobert 2008, 2011). Genetic removal of ast-1 results
in a failure of all dopaminergic neurons to properly
differentiate. A dopaminergic differentiation defect was
Figure 1. ETS-, Pbx-, and homeodomain-binding sites are required for dat-1 expression. (A) Schematic of the dopamine synthesis
pathway genes and a transgenic worm expressing dat-1Tgfp, providing an overview of all dopaminergic neurons in C. elegans. (B)
Summary of previous cis-regulatory analysis of dopamine pathway genes, illustrating with red bars the functionally required ETS
domain-binding sites (EBSs) and sequence logo generated with all functional EBSs (Flames and Hobert 2009). (C) Analysis of the
sufficiency of the EBS (labeled in red) from different dopamine pathway genes, flanked by >10 bp on either side, to drive expression in all
dopaminergic neurons. Two (23) or three (33) copies of each sequence were cloned into the GFP reporter vector. For each construct, at
least two independent lines were analyzed (n > 30 for each line). (+) More than 30% of the cells express GFP; () no GFP expression. (D)
Mutational analysis of the predicted HD (labeled in blue) and Pbx (labeled in green) sites in the context of the trimerized dat-1 DA
motif. For each construct, two independent lines were analyzed. (+) More than 30% of the cells express GFP; () no GFP expression; (+*)
faint expression.
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also observed in olfactory bulb dopaminergic neurons of
mice lacking the AST-1 homolog Etv1 (Flames and Hobert
2009). One key issue that remained unresolved by our
previous studies is the question of specificity. While the
Ets domain transcription factor AST-1 and mouse Etv1
are required to generate dopaminergic neurons, they are
not sufficient to do so, since both genes are expressed in
multiple other, nondopaminergic neuron types. Similar
specificity issues apply to many other terminal selector-
type transcription factors that are required to define the
identity of specific neuron types in vertebrate and in-
vertebrate nervous systems but are often expressed in
many other cell types as well (Hobert 2011; Holmberg and
Perlmann 2012).
Here we investigated this issue of specificity using a
combination of cis-regulatory mutational analysis and
genetic screening approaches. We found that ast-1 indeed
does not act in isolation but rather through a combinato-
rial cis-regulatory signature that is present in the cis-
regulatory regions of all dopamine pathways genes. We
identified three distinct types of trans-acting factors that
recognize this cis-regulatory signature and show that
these factors act together as a ‘‘transcription factor
collective’’ (Junion et al. 2012) to ensure robust execution
of the terminal differentiation program of dopaminergic
neurons. Mouse homologs of this transcription factor
collective are also expressed in a specific population of
dopaminergic neurons in vertebrates, suggesting that our
findings may also apply to mammals.
Results
A combinational cis-regulatory signature required
for gene expression in dopaminergic neurons
We previously showed that a construct containing in
triplicate a 31-base-pair (bp) element from the dat-1
promoter is sufficient to drive expression of a reporter
gene in all eight dopaminergic neurons of the C. elegans
hermaphrodite (Fig. 1C; Flames and Hobert 2009). This
element contains an Ets domain-binding site (EBS), which
we showed through deletion analysis to be essential for
expression of dat-1 in dopaminergic neurons. We found
functional EBSs in all of the dopamine pathway genes and
therefore called the EBS the ‘‘DA motif’’ (Fig. 1B; Flames
and Hobert 2009). Unexpectedly, when we tested the DA
motifs from other dopamine pathway genes in a manner
similar to our testing of the DAmotif from dat-1 (i.e., EBS
plus 13–14 bp of flanking sequences), we found that,
unlike in the dat-1 case, DA motifs from none of the
other four dopamine pathway genes were sufficient to
drive expression in dopaminergic neurons (Fig. 1C) even
though each of the DA motifs is required to drive expres-
sion in all dopaminergic neurons (Flames and Hobert
2009).
We therefore examined the 31-bp DA motif from the
dat-1 promoter in more detail. Using MatInspector soft-
ware analysis, we noted the presence of a predicted Pbx-
type homeodomain (HD)-binding site [‘‘GAT(N)1-2GAT’’]
and a canonical HD-binding site (‘‘TAAT’’) flanking the
EBS. Mutating either site alone had partial effects on the
expression of the reporter gene in dopaminergic neurons,
while mutating both sites simultaneously—leaving, at the
same time, the EBS intact—completely abolished expres-
sion of dat-1 in all dopaminergic neuron types (Fig. 1D).
The DA motif-containing 30- to 32-bp elements from
each of the other four dopamine pathway genes do not
contain a combination of predicted Pbx- and canonical
HD-binding sites, thereby providing a potential explana-
tion for their insufficiency to drive expression in dopa-
minergic neurons. However, each of the minimal regions
from all other dopamine pathway genes driving dopami-
nergic neuron expression contained a set of predicted
Pbx- and HD-binding sites similar to those observed in
the dat-1 promoter. We systematically mutated these
predicted Pbx and HD sites in four of the five dopamine
pathway genes and found that they are required for do-
paminergic neuron expression (Fig. 2A–D). Unlike the
EBS, which is essential for expression of all dopamine
pathway genes (Flames and Hobert 2009), the Pbx and HD
sites act in a partially redundant manner, as detailed below.
dat-1/DAT The minimal dat-1 cis-regulatory element
that drives expression in all dopaminergic neurons (400
bp) contains two predicted HD sites, one predicted Pbx
site, and three functional EBSs (previously shown to be
essential for expression) (Fig. 2A). Mutating a single HD
site has no noticeable effect on dat-1 reporter gene
expression in transgenic animals (data not shown), and
mutating both HD sites has partial effects, similar to the
effect of the HDmutation in the dat-1DAmotif construct
(Figs. 1D, 2A; Supplemental Fig. 1). Mutating the one Pbx
site has no effect (data not shown). However, mutating
both HD sites and the one Pbx site together completely
eliminates reporter gene expression in all dopaminergic
neurons (even though the Ets sites are still present) (Fig.
2A; Supplemental Fig. 1), again in concordance with the
effect seen in the dat-1 DA motif construct analysis.
cat-2/TH The minimal cat-2 cis-regulatory element
that drives expression in all dopaminergic neurons (153
bp) also contains two potential canonical HD sites, one
potential Pbx site, and one functional EBS (previously
shown to be essential) (Fig. 2B). The effects of themutation
of individual sites are similar to the dat-1 case. Mutation
of the first HD site results in partial effects, whereas
mutation of the second HD site does not have any effect.
The combinedmutation of both sites did not significantly
increase the loss of expression (Fig. 2B). Interestingly, the
second HD site that shows no effect when mutated did
not match the ATAAT consensus sequence found for the
dat-1 HD sites (Supplemental Fig. 1). Similarly, mutating
the single Pbx site has a very mild effect. However,
mutating the ATAAT HD site concomitantly with the
Pbx site completely eliminates reporter gene expression
in all dopaminergic neurons (even though the Ets site is
still present) (Fig. 2B; Supplemental Fig. 1).
cat-4/GTPCH In addition to the functionally required
EBS, the minimal cat-4 cis-regulatory element that drives
Regulation of dopaminergic neuron identity
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expression in all dopaminergic neurons (626 bp) has a
substantial number of predicted HD- and Pbx-binding
sites (Supplemental Fig. 1). Through analysis of a smaller
cat-4 promoter region (136 bp) that is active only in
a subset of dopaminergic neurons and subsequent muta-
tion of all HD sites in this small region, we identified one
HD site that matches the ATAAT consensus and whose
mutation resulted in expression defects (Supplemental
Fig. 1). Similar defects where seen when the mutation in
this HD site was introduced in the context of the larger
cat-4 element (which is active in all dopaminergic neu-
rons) (Fig. 2C; Supplemental Fig. 1). If combined with
a mutation in a single Pbx site, expression of the reporter
is completely eliminated (Fig. 2C; Supplemental Fig. 1).
bas-1/AAAD The minimal bas-1 cis-regulatory element
that drives expression in all dopaminergic neurons (143 bp)
also contains one predicted HD site that matches the
Figure 2. The cis-regulatory modules of the dopamine pathway genes. (A–D) Mutational analysis of the cis-regulatory modules of
dopamine pathway genes. (Red bar) Functional EBS; (green bar) predicted Pbx site; (blue bar) predicted HD site. Mutation of the site is
indicated by a black cross and by light shading of the respective bar. For each construct, at least two lines were analyzed (n > 30 for each
line). Wild-type constructs set as 100% expression. (+) Twenty percent expression up or down the wild-type value; (+*) 20% up or down
the wild-type value but faint expression; (+/) >20% decrease compared with wild-type value; () 0%–15% of the cells expressing GFP
in absolute numbers. The primary data for this analysis as well as the nature of each mutation are shown in Supplemental Figure 1. (E)
Summary of the cis-regulatory signature present in the dopamine pathway genes and sequence logo of the functional EBS-, Pbx-, and
HD-binding sites in each minimal cis-regulatory motif.
Doitsidou et al.
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ATAATconsensus, two predicted Pbx sites, and two func-
tional EBSs (previously shown to be essential) (Fig. 2D).
Mutating the single HD site has partial effects on bas-1
reporter gene expression in transgenic animals. Mutating
either Pbx site alone has no or just partial effects, but if
both Pbx sites are mutated, reporter gene expression is
eliminated in all dopaminergic neurons (even though the
EBS is still present) (Fig. 2D; Supplemental Fig. 1).
In conclusion, members of the dopamine pathway are
controlled by a common cis-regulatory signature com-
posed of one or multiple essential EBSs and redundantly
operating HD- and Pbx-binding sites (Fig. 2E). Impor-
tantly, the combination of these three motifs is sufficient
to drive specific expression in all dopaminergic neurons
(Fig. 1D). Notably, there is no defined ‘‘motif grammar’’
(Spitz and Furlong 2012); that is, no specific number,
relative orientation, or spacing of the three motifs defines
this cis-regulatory signature.
The sole C. elegans Distalless/Dlx ortholog, ceh-43,
controls dopaminergic neuron differentiation
To identify the trans-acting factors that act through the
ATAAT HD site, we turned to a collection of mutant
animals that show abnormal expression of the dat-1Tgfp
dopaminergic fate marker and that we isolated previously
through automated sorting of EMS-mutagenized animals
(Doitsidou et al. 2008). One locus that we identified in
this screen is the previously uncloned dopy-2 gene, rep-
resented by four mutant alleles: ot340, ot479, ot406, and
ot345 (Doitsidou et al. 2008). Wemapped this mutant to a
small interval on chromosome III by SNP linkage analysis
and three-factor mapping (see Fig. 4A, below). Through
a combination of transformation rescue analysis (Table 1;
see Fig. 4A, below), whole-genome sequencing (Supple-
mental Table 1), RNAi phenocopy (Table 1), and analysis
of a genetic deletion in the locus (kindly provided by the
C. elegans knockout facility at Tokyo Women’s Medical
School) (Fig. 3B,D), we found that dopy-2 corresponds to
the ceh-43 locus (Fig. 4A,B). Mutations in the ceh-43
locus had not previously been described. From here on,
we refer to dopy-2 as ceh-43.
ceh-43 encodes the sole C. elegans ortholog of the fly
Distalless and vertebrate Dlx homeobox genes (Aspock
and Burglin 2001). In vertebrates, Dlx genes have been
implicated in neuronal patterning (Panganiban and
Rubenstein 2002), but their roles in terminal neuron
differentiation have not previously been described. The
viability of the four alleles isolated from our screen (Table 1)
and the nature of themutations (Fig. 4B) suggest that they
are hypomorphic mutations. Thus, we further analyzed
the involvement of ceh-43 in dopaminergic neuron dif-
ferentiation using the tm480 deletion allele, a likely null
allele. Since animals carrying this allele die as embryos,
we analyzed mosaic animals that specifically lost ceh-43
expression in dopaminergic neurons (see theMaterial and
Methods for details on mosaic analysis). These animals
show defects in the expression of all dopamine pathway
genes and in all dopaminergic neuron types in both the
hermaphrodite (Fig. 3B,D) and the male (data not shown).
The function of ceh-43 is not restricted to controlling
the dopamine pathway genes—it also controls the ex-
pression of other terminal identity markers of dopami-
nergic neurons; namely, the trp-4 and asic-1 ion channel
Table 1. ceh-43 mutant phenotypes
Genotype and reporter
transgenesa
gfp()
CEPV
gfp()
CEPD
gfp()
ADE
gfp()
PDE
Animals
showing
gfp() cells
Animals
with extra
gfp(+) cells
Animals
with any
phenotype n
dat-1Tgfp 0% 6 0% 0% 6 0% 0% 6 0% 0% 6 0% 0% 0% 0% >100
cat-4Tgfp 0% 6 0% 0% 6 0% 0% 6 0% 0% 6 0% 0% 0% 0% >100
cat-2Tgfp 0% 6 0% 0% 6 %0 0% 6 0% 0% 6 0% 0% 0% 0% >100
bas-1Tgfp 0% 6 0% 0% 6 0% 0% 6 0% 0% 6 0% 0% 0% 0% >100
asic-1Tgfp 0% 6 0% 0% 6 0% 0% 6 0% 0% 6 0% 0% 0% 0% >100
ceh-43(ot345); dat-1Tgfp 0% 6 0% 18% 6 4% 6% 6 2% 0% 6 0% 41% 31% 58% 41
ceh-43(ot406); dat-1Tgfp 0% 6 0% 65.9% 6 5% 50% 6 5% 0% 6 0% 95% 16% 97% 60
ceh-43(ot479); dat-1Tgfp 100% 6 0% 100% 6 0% 0% 6 0% 0% 6 0% 100% nd 100% 60
ceh-43(ot340); dat-1Tgfp 100% 6 0% 100% 6 0% 0% 6 0% 0% 6 0% 100% nd 100% >100
ceh-43(ot340); cat-4Tgfp 100% 6 0% 100% 6 0% 0% 6 0% 0% 6 0% 100% nd 100% 40
ceh-43(ot340); asic-1Tgfp 100% 6 0% 100% 6 0% 0% 6 0% 0% 6 0% 100% nd 100% >100
ceh-43(ot340); cat-2Tgfp 100% 6 0% 100% 6 0% 0% 6 0% 0% 6 0% 100% nd 100% 40
ceh-43(ot340); bas-1Tgfp 8% 6 4% 6% 6 3% 0% 6 0% 0% 6 0% 8% 0% 14% 25
ceh-43(ot340); dat-1Tgfp 100% 6 0% 100% 6 0% 0% 6 0% 0% 6 0% 100% 0% 0% 40
ceh-43(ot340); dat-1Tgfp; 2.5% 6 5% 5% 6 6% 0% 6 0% 0% 6 0% 0% nd 0% 6 0% 40
Ex[ceh-43fosmid]
ceh-43(ot340); dat-1Tgfp; 84.3% 6 9% 100% 6 0% 0% 6 0% 0% 6 0% 75% nd 75% 35
Ex[ceh-43DEL_fosmid]
eri-1;lin-15b; dat-1Tgfp 0% 6 0% 0% 6 0% 0% 6 0% 12% 6 3.3% 18% nd 18% 50
empty vector RNAi
eri-1;lin-15b; dat-1Tgfp 21% 6 4% 30% 6 4.5% 36% 6 4.7% 33% 6 4.6% 79% nd 79% 52
ceh-43 RNAi
gfp() refers to dopaminergic neurons showing absence of gfp expression. Adult animals were scored. (nd) Not determined.
aReporters were as follows: vtIs1 (dat-1Tgfp); otIs225 (cat-4Tgfp); otIs254 (cat-2Tgfp); otIs226 (bas-1Tgfp); otIs236 (asic-1Tgfp).
Regulation of dopaminergic neuron identity
GENES & DEVELOPMENT 1395
 Cold Spring Harbor Laboratory Press on May 28, 2014 - Published by genesdev.cshlp.orgDownloaded from 
Figure 3. Loss-of-function and gain-of-function analysis of ceh-43. (A) ceh-43 mutant alleles retrieved from screens for mutants with
loss of dat-1Tgfp expression. (B–D) Mosaic analysis of ceh-43-null mutant animals, showing loss of dopamine pathway genes (B,D) and
no effect on expression of a panneuronal marker (C). For mosaic analysis, inviable null mutant ceh-43(tm480) animals were balanced
with an extrachromosomal array that harbors a rescuing fosmid that contains the ceh-43 locus and a dat-1TmCherry expression
construct that allows assessing for the presence or absence of the array in specific dopaminergic neurons. For phenotypic output,
expression of a chromosomally integrated, gfp-based fate marker was examined. (E) Ectopic expression of ceh-43 under control of the
heat shock leads to embryonic arrest and induction of dat-1Tgfp expression in additional cells. The heat shock was applied at the end of
gastrulation (;300 min after fertilization), and animals were scored ;16 h after heat shock.
Doitsidou et al.
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genes (Table 1; data not shown). The expression of a
panneuronal marker, rab-3, is not affected (Fig. 3C), in-
dicating that ceh-43 does not affect the generation of
dopaminergic neurons but affects the adoption of a spe-
cific neuronal identity. This phenotype is similar to the
loss of the trans-acting factor for the Ets-binding site,
AST-1 (Flames and Hobert 2009).
Twomissense mutations in the ceh-43 locus, identified
through our EMS screen, revealed weaker defects (Figs. 3A,
4B; Table 1). Notably, two other alleles (ot479 and ot340)
are partially overlapping, <2-kb deletions that reside >7 kb
upstreamof the ceh-43 locus (Fig. 4B; Supplemental Table 1).
Both alleles fail to complement the missense alleles
(Doitsidou et al. 2008). In these deletion alleles, a highly
penetrant loss of dopaminergic neuron fate is restricted
entirely to the CEPD and CEPV neuron types, while ADE
and PDE neuron types are unaffected (Fig. 3A; Table 1). As
we show below, both deletions eliminate cis-regulatory
elements required for expression of ceh-43 in the CEPD
and CEPV neurons.
We further corroborated the notion that ceh-43 acts
through the ATAAT motifs by using an in vitro approach
in which we tested whether bacterially produced CEH-43
protein can bind to regulatory elements from four of the
Figure 4. Molecular characterization of ceh-43. (A) Mapping and rescue of the dopy-2 locus. ot340 was mapped with high-throughput
SNP mapping between 7 and 1 cM on LGIII. This interval was further narrowed down to five genes using three-factor mapping
(ot340 was located between unc-93 and dpy-17), deficiency mapping (deficiency strain BC4637 failed to complement, whereas NG2618
and BC4697 complemented ot340), and fosmid rescue (fosmids were injected in three pools of 10; red pool rescued, and subsequently,
fosmids in the rescuing pool were injected as single fosmids; only fosmid WRM0633cC03 rescued). RNAi against ceh-43 recapitulated
the phenotype. (B) Mutant alleles of the ceh-43 locus. Red lines indicate the deletion alleles. Blue boxes of the gene structure denote the
homeodomain. The sequence alignment shows part of the homeodomain, which is affected in the ot406 allele. (C) EMSAs with CEH-43
protein on dat-1, cat-1, cat-4, and cat-2 regulatory elements. CEH-43 binds to ATAAT-containing elements in dat-1, cat-1, cat-4, and
cat-2, in which mutation of ATAAT affects reporter expression in vivo (arrowhead). Mutation of the ATAAT motifs in dat-1 and cat-1
abolishes binding in vitro. CEH-43 does not bind to other TAAT-containing sequences in cat-2 (negative control; left) or cat-4 (negative
control; right), in which mutation of TAAT has no effect on reporter activity in vivo.
Regulation of dopaminergic neuron identity
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dopamine pathway genes. We readily detected such
binding in gel shift assays (Fig. 4C). This in vitro binding
was abrogated when the same ATAAT motifs that dis-
rupted activity in the in vivo reporter gene assay were
mutated (Fig. 4C). This binding is not the result of un-
specific binding to the TAAT core motif, since other
TAAT motifs in the minimal regulatory regions that do
not match to the ATAAT consensus and showed no ac-
tivity in the in vivo reporter assay do not bind CEH-43
(Fig. 4C, negative controls). Two other ceh-43 targets that
we identified in other cellular contexts also contain func-
tional ATAAT-binding sites and bind CEH-43 in vitro
(L Cochella, J Etchberger, N Abe, and O Hobert, unpubl.
data).
ceh-43 not only is required to express terminal fate
markers of dopaminergic neurons, but is sufficient to do
so, at least in some cellular contexts. When misexpressed
under control of a ubiquitous and inducible heat-shock
promoter, up to twice as many dopamine marker-positive
cells can be generated (Fig. 3E). The extent of ectopic
dopaminergic neuron induction upon heat-shocked-
induced ceh-43 expression is similar to the extent of
ectopic dopaminergic neuron induction upon heat-shocked
induction of ast-1 (Flames and Hobert 2009).
ceh-43 is expressed in dopaminergic neurons,
and its function is continuously required to maintain
the differentiated state of dopaminergic neurons
To examine ceh-43 expression, we generated a fosmid-
based reporter in which we recombineered gfp at the
C-terminal end of the ceh-43 locus in the context of an
;32-kb fosmid that contains several genes upstream of
and downstream from ceh-43 (Fig. 5A). Through cola-
beling with a dopaminergic neuron-specific marker, we
found the fosmid reporter to be expressed in all dopami-
nergic neurons throughout the life of the neurons (Fig. 5B).
Expression can also be observed in some additional head
and body neurons as well as nonneuronal cells (Supple-
mental Fig. 2a). This expression was corroborated with
immunostaining of endogenous CEH-43 protein using a
pan-species anti-Distalless antibody (data not shown).
As assessed with immunostaining for CEH-43 and re-
porter transgene for ast-1 expression, despite the broad
neuronal expression of both ceh-43 and ast-1, they
uniquely overlap in dopaminergic neurons plus one addi-
tional pair of nondopaminergic neurons in the head and
one additional neuron in the midbody region (Supplemen-
tal Fig. 2b).
Introducing the smallest of the overlapping deletions
present in the ot340 and ot479 alleles in the context of the
fosmid reporter results in the loss of expression of the
reporter specifically in the CEPD/V neuron types, demon-
strating that these deletions affect relevant cis-regulatory
elements (Fig. 5C). Moreover, we found that ot340 mu-
tants can be rescued with a wild-type fosmid containing
the ceh-43 locus but not by a fosmid in which these reg-
ulatory elements are deleted (Fig. 5D), corroborating the
notion that ceh-43 acts autonomously at least in the CEP
neurons to affect their terminal differentiation.
We noted that animals carrying a missense mutation
in the homeobox of ceh-43 (ot406 allele) show a signifi-
cantly more pronounced defect in the expression of
dopamine markers in adults compared with young
larvae (Fig. 5E). This progressive loss of dopaminergic
neuron identity indicates that ceh-43, like ast-1 (Flames
and Hobert 2009), is continuously required to maintain
the differentiated state of dopaminergic neurons, a typi-
cal feature of terminal selector-type transcription fac-
tors (Hobert 2008).
Cell type- and target gene-specific interactions
of ceh-43 and ast-1
The coexpression of CEH-43 and AST-1 in mature dopa-
minergic neurons as well as the presence of cognate and
functionally required CEH-43- and AST-1-binding sites in
dopamine pathway genes suggest that both proteins co-
operate to activate dopamine pathway genes. The level of
cooperation may differ in distinct dopaminergic neuron
types, as suggested by the observation that in ast-1-null
mutant animals (gk463 allele), the dat-1 gene is still
normally expressed in one dopaminergic neuron type: the
CEPV neurons (Table 2). In ceh-43(ot406) hypomorphic
animals, dat-1 expression in CEPV is also unaffected. In
ast-1(gk463); ceh-43(ot406) double mutants, expression
of dat-1 is now strongly affected in the CEPV neurons
(Table 2). This finding suggests that, in the absence of
ast-1, correct dat-1 expression in the CEPV neurons can
still be ensured by ceh-43, but under such circumstances,
even weak disruptions of ceh-43 activity will severely
affect dat-1 expression. The genetic synergism between
ceh-43 and ast-1 was further confirmed by the analysis of
double-hypomorph mutants (Table 2). In ceh-43(ot406)
mutants, dat-1 expression is only partially affected in the
ADE and CEPD neurons, but this phenotype is greatly
enhanced when the ceh-43(ot406) allele is combined with
the ast-1(hd1) hypomorphic allele, which alone has no
defects in dat-1 expression (Table 2).
These results not only corroborate the genetic interac-
tion of these two factors, but also make the point that
individual dopamine pathway genes may display a differ-
entially tuned requirement for individual trans-acting
factors in specific cell types. In CEPVs, the loss of ast-1
can be tolerated in regard to dat-1 expression because
ceh-43 can ensure robust dat-1 expression, but for other
dopamine pathway genes, loss of ast-1 alone results in
strong defects in expression. Moreover, this is not a gen-
eral compensatory role for ceh-43 because in the other
dopaminergic neurons, the presence of ceh-43 cannot
compensate for a complete ast-1 loss in regard to dat-1
expression.
Two distinct Pbx genes constitute the third component
of the dopamine regulatory signature
To identify the factors that operate through the third
cis-regulatory motif required for dopaminergic neuron
expression, the predicted Pbx HD site, we turned to a
candidate gene approach. The C. elegans genome codes
for three Pbx genes: ceh-20, ceh-40, and ceh-60 (Van Auken
Doitsidou et al.
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et al. 2002; Mukherjee and Burglin 2007). Functions for
these genes in the nervous system have not previously
been reported.
We examined functions for each of the three Pbx genes
in the context of dopaminergic neuron development using
deletion or missense alleles available for each of the loci
(Fig. 6A). We found that ceh-20-null mutants (ok541)
show defects in dat-1Tgfp expression exclusively in the
midbody dopaminergic PDE neuron class (Fig. 6B). Sim-
ilar dat-1Tgfp expression defects in the PDE neurons are
observed in multiple ceh-20 alleles (Table 3). Apart from
dat-1Tgfp, expression of all other members of the dopa-
mine pathway is also defective in the PDE neurons of
ceh-20 mutants (Fig. 6B). The effect of ceh-20 on some of
the members of the pathway (e.g., cat-2) is stronger than
expected from themutation of the Pbx cis-regulatory site.
This may either be indicative of cross-regulation of the
trans-acting factors controlling the dopamine pathway
genes (e.g., ceh-20 regulating dopamine pathway genes
and also regulating ceh-43) or hint toward the presence of
atypical cis-regulatory sites for ceh-20/Pbx.
As in the case of ast-1 and ceh-43, the function of ceh-
20 is not restricted to controlling the dopamine path-
way genes. ceh-20 also controls the expression of other
terminal identity markers of dopaminergic neurons;
namely, the trp-4 and asic-1 ion channel genes [12% of
animals show missing trp-4Tgfp, and 80% show missing
asic-1Tgfp in ceh-20(mu290)mutants; n > 30]. Consistent
Figure 5. Expression pattern of ceh-43. (A) Structure of the fosmid reporter for ceh-43. (B) Expression pattern of the fosmid reporter
(ceh-43fosmidTgfp) and its overlap with dopaminergic markers in adult animals. (C,D) The ot479 allele is a regulatory allele. The allele is
shown in A. (C) Introduction of this deletion into the fosmid reporter abolishes expression of ceh-43 in CEP dopaminergic neurons.
(D) The ability of the wild-type ceh-43 fosmid to rescue the ceh-43(ot340) mutant phenotype is abolished upon introduction of the
ot479 deletion in the fosmid. (E) Sustained expression of ceh-43 in dopaminergic neurons is likely functionally relevant for maintaining
dopaminergic fate. The ot406 allele shows a progressive loss in expression of the dat-1Tgfp marker in ADEs, suggesting a continuous
requirement of ceh-43 gene activity.
Regulation of dopaminergic neuron identity
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with a role in initiating and maintaining the PDE dif-
ferentiation program, a ceh-20 reporter gene construct
is expressed in the PDE neurons throughout their life
(Fig. 6C).
In a fraction of ceh-20(mu290) mutant animals, no
neurons appear to be generated from the post-deirid
lineage, which generates the dopaminergic PDE and
glutamatergic PVD sensory neurons (10% of the animals
Figure 6. Pbx genes controlling dopamine fate. (A) Schematic drawing of alleles used in this study. Red bars indicate the region covered
by the deletion allele. Green boxes of the gene structure denote the homeodomain. Neither ceh-60 nor ceh-40 alleles had been
characterized before. (B) ceh-20 PDE mutant phenotype. Images of dat-1Tgfp expression showing no phenotype for the head neurons
and missing PDE in the ceh-20(ok541)-null allele. Bar graphs show the characterization of the PDE phenotype for all dopamine pathway
genes in ceh-20(mu290) mutants. (C) ceh-20 is expressed in the PDE, and its expression is maintained throughout the life of the worm.
The picture shows expression of a CEH-20TGFP construct. (D) dat-1Tgfp expression in the different Pbx mutant combinations. Due to
the embryonic lethality of ceh-20(ok541); ceh-40(gk159) double mutants, scoring was done in threefold embryos. (E) Quantification of
dat-1Tgfp expression in the different Pbx mutant combinations. The double mutant ceh-20(ok541); ceh-40(gk159) shows a dopami-
nergic neuron differentiation defect that is not significantly enhanced in the triple mutant ceh-20(ok541); ceh-40(gk159) ceh-
60(ok1485). Apart from animals that lack dat-1Tgfp expression, we also frequently observed animals in which additional cells express
dat-1Tgfp. We have not further pursued this phenotype. (F) Genetic interaction between Pbx genes and ceh-43. Quantification of cells
expressing dat-1Tgfp. The defect in dat-1Tgfp expression in a Pbx double-mutant combination of ceh-20(mu290);ceh-40(gk159) alleles
is enhanced by the presence of a hypomorphic ceh-43 allele (ot406). The effect is more than expected from simple additivity.
Table 2. Genetic interactions between ceh-43/Dll and ast-1
Genotype dat-1Tgfp() CEPV dat-1Tgfp() CEPD dat-1Tgfp() ADE n
Wild type 0% 6 0% 0% 6 0% 0% 6 0% >100
ast-1(gk463) 3% 6 4% 100% 6 0% 100% 6 0% 70
ceh-43(ot406) 4% 6 4% 46% 6 5% 35% 6 5% 78
ast-1(gk463); ceh-43(ot406) 100% 6 0% 100% 6 0% 100% 6 0% 50
ast-1(hd1) 0% 6 0% 0% 6 0% 0% 6 0% 100
ceh-43(ot406) 0% 6 0% 59% 6 4% 39% 6 3.9% 152
ast-1(hd1); ceh-43(ot406) 0% 6 0% 92.8% 6 2.3% 46% 6 4.4% 124
Animals were scored at 25°C at the L1 stage. Numbers refer to the percentage of respective neuron that failed to express dat-1Tgfp (vtIs1).
Doitsidou et al.
1400 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on May 28, 2014 - Published by genesdev.cshlp.orgDownloaded from 
generate no neurons in the post-deirid, 14% generate only
one neuron, 37% generate the normal number of two
neurons, and 39% generate more than two neurons; n =
49), suggesting lineage defects. However, the PDE differ-
entiation defects in ceh-20mutants are not merely due to
PDE lineage defects because dat-1 expression is also lost
in animals with an unaffected PDE lineage, as assessed by
correct expression of the pan-neuronal rab-3 marker in
PDE (Supplemental Fig. 3).
In contrast to ast-1 and ceh-43 (Fig. 3E), ceh-20 alone
is not able to induce the production of additional dopa-
minergic neurons upon heat-shock promoter-mediated
misexpression (as assessed by ectopic dat-1Tgfp expres-
sion) (data not shown). Animals that coexpress heat-shock
promoter-driven ceh-43, ast-1, and ceh-20 constructs
show no more ectopic dopaminergic neuron production
than animals expressing ceh-43 or ast-1 alone (data not
shown).
The effect of ceh-20 loss of function is restricted to the
PDE neurons, since the expression of several dopamine
pathway genes is completely unaffected in head dopami-
nergic neurons (Fig. 6B; data not shown). Since our cis-
regulatory analysis indicates that putative Pbx-binding
sites are required for the expression of dopamine pathway
genes in not just PDE neurons but also all dopaminergic
head neurons, we tested whether removal of other Pbx
genes affected dopaminergic head neurons. ceh-40-null
mutants, ceh-60-null mutants, and ceh-40 ceh-60 double-
null mutants did not show defects in dat-1Tgfp expres-
sion in any dopaminergic neuron type (Fig. 6D; Table 3).
However, removal of ceh-40 in a ceh-20 mutant back-
ground, which alone has no effect on head dopaminergic
neurons, results in defects in dat-1Tgfp expression in
head dopaminergic neurons (Fig. 6D; Table 3). In contrast,
combining the ceh-60 mutation with the ceh-20 muta-
tion only shows very mild (<10% penetrant) differentia-
tion defects of head dopaminergic neurons. The defect
of the ceh-20; ceh-40 double mutants are not further
enhanced in ceh-20; ceh-40 ceh-60 triple-null mutants
(Fig. 6E; Table 3). However, the ceh-20; ceh-40 double-
mutant defects are significantly enhanced by removal of
ceh-43/Distalless (ceh-43; ceh-20; ceh-40 triple mutants)
(Fig. 6F), which corroborates the genetic interactions
among distinct members of the dopaminergic regulatory
ensemble. Taken together, ceh-20 functions nonredun-
dantly in the PDE neurons to control their differentiation
but acts redundantly with ceh-40 in head dopaminergic
neurons. Consistent with this notion, we could not detect
expression of ceh-40 in the midbody PDE neuron but
detected expression of both ceh-20 and ceh-40 in the head
dopaminergic neurons (Supplemental Fig. 4).
We examined the overlap of ast-1, ceh-43, and Pbx gene
expression to assess whether their coexpression uniquely
defines dopaminergic neurons. We detected coexpression
of ast-1, ceh-43, and ceh-20 in at least one nondopami-
nergic neuron (SDQL). The two most likely possibilities
that could explain this lack of specificity are that either
there are still other components of the dopaminergic
transcription factor collective that remain to be identified
and are not expressed in SDQL (those are unlikely to be
DNA-binding factors, since the ETS, HD, and Pbx sites
are sufficient to exclusive drive gene expression in
dopaminergic neurons) or, alternatively, repressive mech-
anisms could operate in SDQL to inhibit the expression
of dopaminergic neuron identity.
We also investigated whether ast-1, ceh-43, and ceh-20
cross-regulate each other’s expression. Focusing on the
PDE neuron class, we found that ast-1 expression is un-
affected in ceh-43 and ceh-20 mutants (data not shown).
However, ast-1 is required for ceh-43 expression (Supple-
mental Fig. 5) but is not required for ceh-20 expression
(data not shown). These results indicate that these factors
act to some extent independently of one another.
Taken together, our reverse genetic analysis identified
a third component of the regulatory signature of dopa-
minergic neuron terminal differentiation programs. As
Table 3. Pbx genes affecting dopaminergic neuron differentiation
Loss of dat-1Tgfp expression
in all or a subset of head neurons
(ADE and CEPs)
Loss of dat-1Tgfp expression
of midbody neurons (PDE) n
Wild type 0% 6 0% 3% 6 2% 55
ceh-20(ok541) 0% 6 0% 55% 6 7%a 56
ceh-20(ay42) 0% 6 0% 54% 6 8% 39
ceh-20(ay38) 0% 6 0% 40% 6 8%b 39
ceh-20(mu290) 0% 6 0% 50% 6 7%c 56
ceh-40(gk159) 0% 6 0% 0% 6 0% 50
ceh-60(ok1485) 0% 6 0% 0% 6 0% 50
ceh-40(gk159), ceh-60(ok1485) 0% 6 0% 0% 6 0% 52
ceh-20(ok541); ceh-40(gk159) 38% 6 5%d Not scorable due to embryonic lethality 86
ceh-20(ok541); ceh-60(ok1485) 9% 6 4%e 50% 6 6% 66
ceh-20(ok541); ceh-40(gk159), ceh-60(ok1485) 53% 6 4%f Not scorable due to embryonic lethality 126
aok541 allele 5% of the escapers show extra GFP cells in PDE region
bay38 allele 11% of the escapers show extra GFP cells in PDE region
cmu290 allele 5% of animals show extra GFP cells in PDE region
dThirty-six percent of the embryos show extra GFP cells
eFourteen percent of the embryos show extra GFP cells
fTwenty-four percent of the embryos show extra GFP cells
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predicted by the cis-regulatory analysis, this third com-
ponent is a Pbx gene. In one dopaminergic neuron type,
only one Pbx gene is required; in other dopaminergic
neuron types, a combination of Pbx genes act redundantly.
AST-1, CEH-43, and CEH-20 cooperate to activate
dopamine pathway genes in a heterologous, cell-based
cis-activation assay
To further explore the mechanistic basis of the interac-
tion of AST-1, CEH-43, and a Pbx factor in controlling and
maintaining dopaminergic neuron identity, we turned
to a yeast transcription assay (Topalidou et al. 2011). We
inserted the regulatory regions of two of the dopamine
pathway genes, bas-1 and cat-2, upstream of the yeast
minimal cyc-1 promoter to drive the expression of
b-galactosidase in the presence of different combinations
of AST-1, CEH-43/Dll, and CEH-20/Pbx. We found that
expression of neither factor alone is able to induce gene
expression, but expression of all three factors together
results in very strong induction of gene expression (Fig. 7).
In double combinations, only combinations with AST-1
yield induction of gene expression, albeit at lower levels
than the triple combination (Fig. 7). These findings support
a model in which all three factors work in a cooperative
manner to control gene expression.
The partial activity of AST-1 in combination with either
CEH-43 or CEH-20 observed in the yeast assay matches
with the general theme revealed by the cis-regulatory
analysis: While Ets-binding sites are always essential for
reporter gene expression, the loss of either HD or Pbx
cis-regulatory sites can sometimes be tolerated, likely
because AST-1 can still operate with the remaining cofactor.
Discussion
We described here a regulatory signature that specifies
the terminal differentiation program of all dopaminergic
neurons in C. elegans. We found that a combination of
three cis-regulatory motifs is sufficient to dictate exclu-
sive gene expression in all dopaminergic neurons of theC.
elegans nervous system. This cis-regulatory signature is
recognized by a combination of three types of trans-
acting factors: an Ets domain factor, a Dlx-type HD, and
Pbx-type HD proteins. These proteins work as terminal
selectors to initiate and maintain the terminally differ-
entiated state of C. elegans dopaminergic neurons. The
mutant phenotypes of all three types of regulatory factors
are similar to each other and are also similar to the
phenotypic consequences of removal of terminal selector
transcription factors that control terminal differentiation
of otherC. elegans neuronal cell types (Hobert 2008, 2011):
Neurons are generated and still express panneuronal
features but fail to adopt neuron-type-specific properties
(in this case, the terminal features that define dopami-
nergic identity).
Early patterning roles have been described for Pbx
genes in several different contexts in both vertebrates and
invertebrates (Laurent et al. 2008), but a function of Pbx
genes in directly controlling post-mitotic, terminal dif-
ferentiation programs has not yet, to our knowledge, been
described in any system to date. Notably, the role of
C. elegans Pbx genes in controlling dopaminergic neuron
fate appears to be independent of the function of Hox
genes, which are common interaction partners for Pbx
genes in many cellular contexts (Moens and Selleri 2006;
Laurent et al. 2008). The anterior-most expression bound-
ary of the most anterior HOX cluster gene, ceh-13, does
not cover the region where the dopaminergic neuron
classes ADE, CEPD, and CEPV are located (Wittmann
et al. 1997). As expected, ceh-13-null mutants do not af-
fect dopaminergic neuron marker gene expression (our
unpublished observations). Even though the role of Pbx
as a Hox cofactor has been well documented, Hox-
independent functions of Pbx family members have been
Figure 7. Cooperative gene activation by the AST-1/CEH-43/CEH-20 transcription factor collective. AST-1, CEH-43, and CEH-20 cooperate
to induce transcription in yeast cells. AST-1, CEH-43, and CEH-20 or their combinations were expressed in yeast cells together with the
bas-1pTlacZ (left panel) or cat-2pTlacZ (right panel) reporters. Values are the mean6 SEM of two to five replicates. P < 0.02, Student’s t-test.
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described in several species, includingC. elegans (Yang et al.
2005), vertebrates (Ferretti et al. 2011), and flies (e.g., Casares
andMann 2001; Bessa et al. 2002). Intriguingly, one study in
Drosophila has shown that the ceh-43 ortholog Distalless
genetically interacts with the fly Pbx homolog Exd (Dong
et al. 2000). The function of worm Pbx genes in controlling
dopaminergic neuron differentiation is also independent
of another common cofactor of Pbx gene, the Meis-type
homeobox gene. There is a single canonical Meis homolog
in the C. elegans, encoded by the unc-62 loucs (Van Auken
et al. 2002), but animals carrying a nullmutant allele of unc-
62 show no reduction in the production of dopaminergic
neurons (our unpublished observations).
As revealed through the use of a heterologous yeast
transcriptional assay system, the Ets/Dlx/Pbx regula-
tory ensemble acts in a cooperative manner to activate
gene expression. Cooperativity is also suggested by ge-
netic interaction tests that show synergy (rather than
additivity) in loss-of-function scenarios. The cooperativ-
ity is reminiscent of the terminal differentiation program
executed by the cholinergic AIY interneuron class in C.
elegans. Here again, two factors (the HD transcription
factors ttx-3 and ceh-10), each expressed in a number of
distinct neuron types, uniquely overlap in their expres-
sion in the AIY interneurons, where they cooperatively
activate scores of terminal differentiation genes that
define AIY interneuron identity (Wenick and Hobert
2004). The key conceptual and mechanistic difference
between the cooperativity of ttx-3/ceh-10 and ast-1/ceh-
43/Pbx lies in what generally is referred to as the
‘‘grammar’’ of cis-regulatory logic; that is, the overall
organization of the individual cis-regulatory motifs. In
the case of theAIY-expressed, ttx-3/ceh-10-dependent reg-
ulatory elements, the two binding sites for TTX-3 and
CEH-10 are precisely spaced and oriented to allow for
cooperative binding. Contrasting such fixed grammar, the
cis-regulatory regions that control dopaminergic neuron
expression are composed of cis-regulatory sites (ETS
domain, HD, and Pbx-binding site) that display no fixed
spacing, relative orientation, or overall number of in-
dividual sites, yet the activity of the cis-acting factors is
nevertheless cooperative, as determined by mutant anal-
ysis and heterologous transcription assays in yeast. A
recently published study described a similar regulatory
architecture for cardiac gene expression in Drosophila
and proposed the term ‘‘transcription factor collective’’
(Junion et al. 2012). In that case, five cardiogenic tran-
scriptional regulators cooperatively activate target genes
in the absence of a defined motif grammar, and in some
target cases, only a subset of the these factors are bound.
Our studies broaden this concept to a different cell type
and organism, suggesting universality of this regulatory
mechanism.
We further extend the transcription factor collective
model by our ability to examine its activity in four distinct
neuronal subclasses: ADE, CEPD, CEPV, and PDE. Even
though these four dopaminergic classes share many mo-
lecular and functional features, these neurons have distinct
lineage histories and distinct axo/dendritic projections
and are located in different parts of the nervous system.
Even though our cis-regulatory analysis in combination
with our genetic analysis clearly shows that all four
neuron classes employ this combination of regulatory
factors, the extent of the involvement of individual
factors differs for each individual dopamine pathway gene
in individual dopaminergic neuron subtypes. For exam-
ple, dat-1 expression critically depends on ast-1 expres-
sion in all neurons except for the CEPV neurons, in which
ast-1 function can be compensated for by ceh-43 gene
activity. Head dopaminergic neuron types rely on multiple
Pbx genes, as amutant phenotype is only evident in double-
mutant combinations, while midbody dopaminergic neu-
rons critically depend on only one Pbx gene (ceh-20). The
underlying common theme of all of these interactions
may be that the presence of multiple factors ensures robust
expression of the target genes of these transcription factors
and that each cell and target genemay use slightly different
although related means to ensure this robustness.
The same Ets/Dlx/Pbx regulatory signature that we
describe here may also function in dopaminergic neurons
in vertebrates. We showed previously that Etv1, a mouse
homolog of ast-1, is required for the appropriate differen-
tiation of olfactory dopaminergic neurons (Flames and
Hobert 2009). The defects of Etv1 mutants, however, are
not as pronounced as ast-1 mutant defects are; for exam-
ple, while TH expression is affected by Etv1, DAT ex-
pression is not (Cave et al. 2010). One potential expla-
nation for this partial effect can be seen in the regulatory
logic described here: Other factors that cooperate with
Etv1 may partially compensate for its loss. In fact, the
failure to see a loss of Dat expression in Etv1 mouse
mutants (Cave et al. 2010) may precisely mirror the
absence of a phenotype of dat-1 expression in the CEPV
neurons of ast-1-null mutants; that is, the ast-1 pheno-
type is only revealed if a cooperating factor (in this case,
ceh-43) is disabled.
The factors that cooperate with vertebrate Etv1 to
ensure dopaminergic neuron differentiation in the olfac-
tory bulb could be the same as we defined here in C.
elegans. A null mutation of Dlx2 results in early speci-
fication defects of olfactory bulb neurons and a loss of
TH-positive neurons (Qiu et al. 1995). Dlx2 expression is
maintained in adult dopaminergic neurons, and later
function of Dlx2 in terminal differentiation specifically
of the dopamine olfactory bulb neurons is suggested
through expression of a dominant-negative form of Dlx2,
which resulted in dopaminergic neuron specification
defects (Brill et al. 2008). To assess whether the third
component of the worm Ets/Dlx/Pbx regulatory signa-
ture is also expressed in mouse olfactory bulb dopami-
nergic neurons, we stained mouse olfactory bulbs with
a Pbx1/2/3 antibody and observed Pbx immunoreactivity
in TH-positive neurons (Supplemental Fig. 6). Intrigu-
ingly, Pbx1 is expressed in the midbrain dopaminergic
neurons, and Pbx1 mutants show dopaminergic axon
pathfinding defects (Sgado et al. 2012). These observa-
tions suggest that the regulatory code between olfactory
bulb dopaminergic neuron specification and worm dopa-
minergic neuron specification could, at least in part, be
phylogenetically conserved.
Regulation of dopaminergic neuron identity
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Materials and methods
DNA constructs and cis-regulatory analysis
All gfp-based reporter constructs were generated using the
pPD95.75 vector as backbone and by subcloning into the multiple
cloning site. Mutagenesis reactions were performed using the
QuickChangeII XL site-directed mutagenesis kit (Stratagene).
Constructs were injected or crossed into otIs181 (dat-1Tcherry;
ttx-3Tcherry) to allow easy identification of dopaminergic neu-
rons. All reporter constructs were injected at 50 ng/mL using
rol-6(su1006) as a coinjection marker (100 ng/mL). For each
construct, two or three independent lines were scored (at least 30
animals per line). Sequences of the wild-typeminimal constructs
are in the Supplemental Material, and the nature of the muta-
tions introduced is indicated in Supplemental Figure 1.
Cloning of dopy-2/ceh-43
ot340 was mapped with high-throughput SNP mapping (Davis
et al. 2005) between 7 and 1 cM on LGIII. Three-factor
mapping mapped ot340 between unc-93 and dpy-17. Deficiency
mapping placed the ot340 locus within deficiency BC4637 but
outside deficiencies NG2618 and BC4697. Fosmid rescue of
pools of fosmids were injected, followed by single-fosmid injec-
tions of the fosmids included in the rescuing pool. Single-fosmid
injection of WRM0633cC03 rescued the ot340 phenotype. Only
five genes were included in the rescuing fosmid. RNAi against
each of these genes was performed using a bacterial feeding
protocol (Kamath and Ahringer 2003) in an eri-1;lin-15b;vtIs1
mutant background (Kennedy et al. 2004). RNAi against ceh-43
recapitulated the phenotype. Sanger sequencing revealed point
mutations in the ceh-43 locus for ot406 and ot345 alleles but
no mutation in alleles ot340 and ot479.Whole-genome sequenc-
ing using an Illumina platform followed by data analysis using
MAQGene (Bigelow et al. 2009) of ot340 and ot479 revealed two
overlapping deletions >7 kb upstream of ceh-43 CDS (Supple-
mental Table 1). Deletions were confirmed by Sanger sequenc-
ing to span genomic regions on LGIII from 4457789 to 4459806
(2018 bp) for ot340 and from 4458889 to 4459754 (866 bp) for
ot479.
Fosmid recombineering and ceh-43 expression analysis
ceh-43-containing fosmid WRM0633cC03 was tagged as
described before (Tursun et al. 2009) to generate OH9993
(otEx4439[ceh-43fosmidTgfp;ttx-3Tdsred;rol-6]) and integrated to
generate OH10447 (otIs339[ceh-43fosmidTgfp;ttx-3Tdsred;rol-6]).
The ot479 deletion was engineered in the recombineered
fosmid as described before (Tursun et al. 2009) to generate
DEL_ceh-43fosmidTgfp. For determining the neuronal expression
of ceh-43, strainMDH33 (otIs339[ceh-43fosmidTgfp;ttx-3Tdsred;rol-
6];otIs355[rab-3TNLSTtagRFP]) was used. To determine ceh-43
expression in ast-1mutants, strainMDH38 {ast-1(gk463) bli-2(e768)
unc-4(e120);Ex[ast-1cosmid;ttx-3Tgfp;dat-1TmCherry];otIs339;
otIs355} was used.
The ability of the recombineered fosmid with and without the
deletion to rescue ceh-43(ot340) mutants was assessed using
strains OH10412 {ceh-43(ot340);vtIs1; otEx4439[ceh-43fosmidT
gfp;ttx-3Trfp;rol-6]} and OH10424 {ceh-43(ot340); vtIs1;[ExDEL_
ceh-43fosmidTgfp;ttx-3Trfp;rol-6]}, respectively.
Mosaic analysis
The strain CH1890 {ceh-43(tm480)/qC1 e1259q339[gIs26]}
was injected with ceh-43 fosmid WRM0633cC03 (15 ng/mL)
and dat-1TmCherry (40 ng/mL) to generate the strain ceh-43
(tm480);Ex[ceh-43fosmid;dat-1TmCherry]. This balanced strain
was then crossed with animals bearing chromosomally in-
tegrated, gfp-based transgenes that monitor expression of dopa-
mine pathway genes. Mosaic animals were identified by the loss
of dat-1TmCherry in one or more dopaminergic neurons, and
the fate of these neurons was assessed by scoring the expression
of the integrated transgene. Note that the experimental design of
this mosaic analysis does not allow distinguishing between loss
of the array and inability of the array to rescue the mutant
phenotype; that is, animals that fail to show dat-1TmCherry
may carry the array containing dat-1Tmcherry and the ceh-43
fosmid, but ceh-43 fails to rescue the dat-1 expression defect, and
this is why no dat-1TmCherry expression is observed in the cell.
This very failure of ceh-43 to rescue the expression of the dat-1T
mCherry phenotype implies that ceh-43 mutation has an effect
on dat-1 expression to begin with. Thus, any dopaminergic
phenotype in ceh-43-rescued mutant worms attests to a role of
che-43 in dopaminergic fate whether this phenotype is caused by
loss of the array per se or its inability to rescue with 100%
penetrance.
Ectopic expression of ceh-43
ceh-43 under control of the heat-shock promoter was injected
into vtIs1[dat-1Tgfp] to generate the strain Ex[hsp-16.2Tceh-
43;hsp-16.2TNLS-mCherry;ttx-3Tds-red];vtIs1. The heat shock
was applied at the end of gastrulation (;300 min after fertiliza-
tion), and animals were scored ;16 h after heat shock.
Protein purification, EMSA, and yeast transcription assay
Full-length His-tagged CEH-43 was expressed in BL21 cells and
purified using Co2+ chromatography. EMSAs were performed
as previously described (Gebelein et al. 2002). For all EMSAs,
CEH-43 was tested at two concentrations: 60 nM and 180 nM.
Probe sequences are listed in the Supplemental Material.
For the yeast assays, the reporter plasmids bas-1pTlacZ and
cat-2pTlacZ were constructed by cloning the 279 bp and 354 bp
upstream of the ATG of the bas-1 and cat-2 genes, respectively,
into the HindIII/XmaI sites of plasmid pXCZ55 (a gift fromMark
Ptashne). Yeast strains expressing bas-1pT lacZ and cat-2pTlacZ
were constructed by digesting plasmids with these DNAs with
ApaI and integrating them in the URA locus of the yeast strain
YPH499 (Stratagene). Positive colonies were identified using
single-colony PCR. Yeast transformation was performed using
the Liac/SS carrier DNA/PEG method (Gietz and Woods 2002).
Induction was achieved as described previously (Topalidou
et al. 2011), and cells were harvested when OD600 = 1.5. Liquid
b-galactosidase assays were performed as described by Reynolds
et al. (2001).
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